Connect with us
Prague Gaming & TECH Summit 2025 (25-26 March)

Blockchain Press Releases

Frost & Sullivan Awarded Duopharma Biotech with the 2022 Malaysian Company of the Year Award

Published

on

frost-&-sullivan-awarded-duopharma-biotech-with-the-2022-malaysian-company-of-the-year-award

Duopharma Biotech is the first pharmaceutical company to offer biosimilar products in the Malaysian market.

SAN ANTONIO, July 27, 2023 /PRNewswire/ — Frost & Sullivan recently researched the Malaysian biosimilars industry and, based on its findings, recognizes Duopharma Biotech Berhad (Duopharma Biotech) with the 2022 Malaysian Company of the Year Award. Duopharma Biotech delivers accessible and affordable healthcare to the Malaysian population by leveraging biosimilars, which are scientifically approved alternatives to drugs derived from biological sources.

Biosimilars typically cost between $100 million and $200 million to develop, while original drugs cost around $2.6 billion and take over a decade of testing. Consequently, biosimilar drugs are more affordable for Malaysian patients and are a cost-effective alternative to original drugs.

Healthcare professionals and patients benefit from Duopharma Biotech’s products because its biosimilars are an excellent choice for managing diabetes, cancer, and renal anemia. For medications to remain affordable, the company commercialize a wide range of biosimilars, such as Zuhera and Krabeva for cancer treatment and ERYSAA®, a biosimilar of Epoetin Alfa, for dialysis patients. These products position Duopharma Biotech as a leading supplier of biosimilars in Malaysia and in the Association of Southeast Asian Nations (ASEAN). Erysaa has also been successfully registered and commercialised in the Philippines.

“One of Duopharma Biotech’s competitive advantages in ASEAN is its uniquely diverse product portfolio, which allows it to compete with other market participants. Duopharma Biotech has launched biosimilars Zuhera and Krabeva for the Cancer Care Franchise as well as Insugen and Basalog One for the Diabetes Care Franchise. In addition, Duopharma Biotech’s first biosimilar ERYSAA® received its Halal certificate from the Korea Muslim Federation (KMF) in 2020 and 2021. It is the world’s first Halal-certified biosimilar used for dialysis patients,” said Dr. Maeirah Ashaie, Best Practices Research Consultant at Frost & Sullivan.

Advertisement

An increase in sales in 2021 supports the popularity and competitiveness of Duopharma Biotech biosimilars in the market. ERYSAA®‘s performance was impressive since its sales increased by 52%, with dialysis centers and hospitals prescribing ERYSAA® for patients in approximately 49% of cases.

This exceptional financial performance is due to Duopharma Biotech’s commitment to delivering high-quality products and services that exceed customers’ expectations and meet local and international regulatory requirements. Throughout the quality policy, the company is fully committed to understanding and meeting customer needs with superior customer service.

“Duopharma Biotech’s quality policy outlines its commitment to building trust by offering products and services that satisfy customers’ expectations and comply with local and overseas regulatory and quality requirements. The quality policy requires Duopharma Biotech to understand and fulfill customer requirements, provide a high standard of service to internal and external customers, continuously engage and delight customers and stakeholders, and improve processes, products, and services continuously,” noted Ashaie.

Each year, Frost & Sullivan presents a Company of the Year award to the organization demonstrating excellence in growth strategy and implementation in its field. The award recognizes a high degree of innovation with products and technologies and the resulting leadership in customer value and market penetration.

Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

Advertisement

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Contact:
Tammy Chan
[email protected] 

About Duopharma

Duopharma Biotech Group (“Duopharma Biotech” or “the Company”) began with the establishment of Duopharma (M) Sendirian Berhad in 1978. Duopharma Biotech was incorporated in 2000 and is today one of Malaysia’s leading pharmaceutical companies listed on the Main Market of Bursa Malaysia Berhad.

Advertisement

Duopharma Biotech has core competencies in the pharmaceutical industry inclusive of Manufacturing, Research & Development, and Commercialization & Marketing of over 300 generic drugs such as Crystorvas, Prelica, and Omesec as well as Consumer Healthcare (“CHC”) products including CHAMPS®, FLAVETTES®, PROVITON®, and Uphamol, which are well-recognized and accepted by consumers in Malaysia, regionally and globally. The Company has also diversified into the biosimilars space with technology and commercialization collaborations with credible and strong international partners. ERYSAA®, Basalog One®, and Zuhera are a few commercialized biosimilar brands.

Headquartered in Kuala Lumpur, Malaysia, Duopharma Biotech owns and operates three manufacturing plants in Klang, Bangi, and Glenmarie, Selangor. Duopharma Biotech also has subsidiary companies in the Philippines, Singapore and Indonesia.

Website: www.duopharmabiotech.com

Logo – https://mma.prnewswire.com/media/2160953/Duopharma_Biotech_Berhad_Biosimilars_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/frost–sullivan-awarded-duopharma-biotech-with-the-2022-malaysian-company-of-the-year-award-301886072.html

Advertisement
Continue Reading
Advertisement

Blockchain Press Releases

KuCoin Launches KuCoin Pay, a Merchant Solution Leading the Future of Crypto Payments

Published

on

kucoin-launches-kucoin-pay,-a-merchant-solution-leading-the-future-of-crypto-payments

VICTORIA, Seychelles, Jan. 2, 2025 /PRNewswire/ — In a significant leap forward for digital commerce, KuCoin has unveiled KuCoin Pay, a pioneering merchant solution designed to catalyze business growth by integrating crypto payments into the retail sector. This innovative system bridges the gap between traditional retail and crypto, offering contactless and borderless transactions. Leveraging KuCoin’s robust infrastructure—trusted globally and serving over 37 million+ users – KuCoin Pay is poised to open new opportunities for merchants and users to thrive in the evolving digital economy.

KuCoin Pay is committed to reducing transaction fees and facilitating immediate settlement of crypto payments, simplifying the process for businesses to manage transactions efficiently. The platform supports an extensive range of cryptocurrencies and blockchain networks, significantly broadening the global reach of payments.

The process for merchants is straightforward: integrate KuCoin Pay into their payment systems, allowing customers to complete purchases through KuCoin by scanning a QR code or via the KuCoin app. This integration ensures a frictionless checkout experience, fostering greater consumer confidence and satisfaction.

Additionally, KuCoin Pay is integrated within the KuCoin app, enabling businesses to tap into KuCoin’s extensive user base while simplifying the buying process for everyday items for users. Daily requests such as gift cards and mobile top-ups can be done seamlessly, further promoting widespread crypto adoption.

KuCoin Pay represents a major milestone in driving the mainstream adoption of crypto and marks a pivotal step in KuCoin’s ongoing commitment to enriching the blockchain ecosystem. For more information on KuCoin Pay and how it can transform your business, please visit the KuCoin Pay website.

Advertisement

About KuCoin

Founded in 2017, KuCoin is one of the pioneering and most globally recognized technology platforms supporting digital economies, built on a robust foundation of cutting-edge blockchain infrastructure, liquidity solutions, and an exceptional user experience. With a connected user base exceeding 37 million worldwide, KuCoin offers comprehensive digital asset solutions across wallets, trading, wealth management, payments, research, ventures, and AI-powered bots. KuCoin has garnered accolades such as “Best Crypto Apps & Exchanges” by Forbes and has been recognized among the “Top 50 Global Unicorns” by Hurun in 2024. These recognitions reflect its commitment to user-centric principles and core values, which include integrity, accountability, collaboration, and a relentless pursuit of excellence.

Logo – https://mma.prnewswire.com/media/2356857/KuCoin_Horizontal_Green_LOGO_Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/kucoin-launches-kucoin-pay-a-merchant-solution-leading-the-future-of-crypto-payments-302341049.html

Continue Reading

Blockchain Press Releases

KuCoin Advances the “Menstrual Equity Project”, Benefiting 4,000 Women in the Bahamas

Published

on

kucoin-advances-the-“menstrual-equity-project”,-benefiting-4,000-women-in-the-bahamas

NASSAU, Bahamas, Jan. 2, 2025 /PRNewswire/ — On December 31, 2024, the “Menstrual Equity Project” , jointly initiated by KuCoin, Global CSR Foundation, and the American Medical Women’s Association (AMWA), has made new progress. The second batch of aid supplies has been successfully shipped to the Bahamas, providing urgently needed sanitary products for 4,000 local women and effectively improving their quality of life.

The “Menstrual Equity Project” aims to offer sustainable menstrual hygiene solutions to marginalized women and girls, aligning with the United Nations’ Sustainable Development Goals (SDGs). As the oldest multi-specialty medical organization promoting women’s advancement in the medical field and improving women’s health, AMWA’s mission is in perfect alignment with KuCoin’s commitment to social responsibility.

With the support of the Office of the First Lady of Commonwealth of Bahamas H. E. Ann Marie Davis, this round of donated materials focuses on disposable menstrual pads. This decision reflects the local challenges of water scarcity and high washing costs, while also providing essential emergency supplies for women during natural disasters such as hurricanes and typhoons.

Since KuCoin made a firm commitment to social welfare initiatives during the “KuCoin Green Future Gala” at the 28th United Nations Climate Change Conference (COP28) in 2023, the company has actively fulfilled its corporate social responsibilities. The “Menstrual Equity Project” has become a key initiative under this commitment.

In March 2024, the project’s first phase was implemented, distributing 1,000 menstrual kits—each containing 10 sanitary pads and 2 menstrual cups—to Suriname, St. Jude Children’s Research Hospital, and domestic violence shelters in New York and California.

Advertisement

The smooth delivery of the second batch of supplies to the Bahamas will benefit 4,000 women.

Jing Zhao Cesarone,President of Global CSR Foundation, commented:”KuCoin has set a remarkable example in addressing period poverty in underserved regions, demonstrating its enthusiasm and dedication to social responsibility.”

Nancy Cheung, KuCoin’s Chief Sustainability Officer (CSO), emphasized:”As a global leader in the digital economy, KuCoin is committed to advancing the UN’s Sustainable Development Goals (SDGs). Looking ahead, we will continue to focus on key areas such as climate change, health, and education, driving more philanthropic initiatives to fruition. We also plan to expand the scope of the ‘Menstrual Equity Project,’ collaborating with more international organizations to improve women’s living conditions and contribute to global sustainable development.”

About KuCoin

Founded in 2017, KuCoin is one of the pioneering and most globally recognized technology platforms supporting digital economies, built on a robust foundation of cutting-edge blockchain infrastructure, liquidity solutions, and an exceptional user experience. With a connected user base exceeding 37 million worldwide, KuCoin offers comprehensive digital asset solutions across wallets, trading, wealth management, payments, research, ventures, and AI-powered bots. KuCoin has garnered accolades such as “Best Crypto Apps & Exchanges” by Forbes and has been recognized among the “Top 50 Global Unicorns” by Hurun in 2024. These recognitions reflect its commitment to user-centric principles and core values, which include integrity, accountability, collaboration, and a relentless pursuit of excellence.

Advertisement

Logo – https://mma.prnewswire.com/media/2356857/KuCoin_Horizontal_Green_LOGO_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/kucoin-advances-the-menstrual-equity-project-benefiting-4-000-women-in-the-bahamas-302341084.html

Continue Reading

Blockchain Press Releases

Bybit Launchpad Onboards Xterio, Opening up Opportunities in Blockchain Gaming for Users

Published

on

bybit-launchpad-onboards-xterio,-opening-up-opportunities-in-blockchain-gaming-for-users

DUBAI, UAE, Dec. 31, 2024 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, is excited to announce the next major Launchpad project, Xterio token (XTER), with 7,500,000 XTER in rewards for early subscribers. Bybit users now have the opportunity to delve into the GameFi economy and earn rewards through two stages: by subscribing to the token on Bybit Launchpad by Jan. 7, and by completing simple tasks to unlock additional prize pools following XTER’s Spot listing on Jan. 8.

Xterio is an AI-powered blockchain gaming platform built on the Layer 2 OP Superchain ecosystem. Xterio’s innovative approach to combining gaming and rewards has attracted high-caliber investors and developers. The project has raised over $80 million in funding and boasts strong backing from Binance Labs, Makers Fund, DST Global, and over 70 partners.

XTER Subscription – How to Participate:

During the subscription period, users have two options to share in the 7,500,000 XTER rewards:

  • Subscribing to Buy XTER with MNT for a chance to win from the total pool of 3,750,000 XTER (with an individual cap of 7,500 XTER).
  • Joining the lottery with USDT to win XTER allocation from another 3,750,000 XTER prize pool (with an individual cap of 4 lottery tickets per users).

To participate, eligible users must maintain a daily average balance of 50 MNT or 100 USDT during the Snapshot Period from Jan. 3 to 7, 2025. The required amount must be committed during the Subscription Period from 3:30 AM UTC to 8:50 AM UTC on Jan. 8, and tokens will be allocated by 9:59 AM UTC on the same day.

XTER Spot Listing – More Rewards Head

Advertisement

From Jan. 7 to 22, 2025, Bybit users can also unlock two additional XTER prize pools by completing simple tasks:

  1. Users may register for the XTER Token Splash and complete deposit and trading tasks for a chance to earn from a 300,000 XTER prize pool; and
  2. The XTER Puzzle Hunt allows participants to collect puzzle pieces to unlock another 300,000 XTER prize pool.

Xterio on Bybit Web3: A Rising Star in Blockchain Gaming

Xterio also provides a robust and vibrant ecosystem through its strategic partnerships. Recently featured on Bybit Web3’s GameFi SNZ, Xterio ranked 4th among a formidable list of contenders, where its supporters shared a 38,000 XTER prize pool on Bybit.

By subscribing to and trading the native XTER token, Bybit users have the chance to get ahead in the rapidly growing blockchain gaming sector.

“We are excited to bring Xterio to Bybit Launchpad, offering our users a unique opportunity to get in early on the future of blockchain and AI gaming,” said Emily Bao, Head of Web3 and Spot at Bybit.

Bybit Launchpad offers a transparent platform allowing users to participate in high-potential blockchain projects at attractive prices in the early stages. Curated by blockchain experts, Launchpad projects often gain strong community support before landing on Bybit Spot, where users benefit from the platform’s robust infrastructure, safe trading environment, and deep liquidity.

Advertisement

For a detailed timeline on Bybit Launchpad and Bybit Spot, (terms and conditions apply), users may find out more from the announcement – Xterio (XTER) on Bybit Launchpad 3.0: Now Live, and visit Bybit Launchpad.

#Bybit / #TheCryptoArk

About Bybit
Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 60 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: [email protected]
For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

Advertisement

Logo – https://mma.prnewswire.com/media/2267288/Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/bybit-launchpad-onboards-xterio-opening-up-opportunities-in-blockchain-gaming-for-users-302340608.html

Continue Reading
Advertisement
 title=
Advertisement

Latest News

Recent Listings

  • Global Payout, Inc.

    Since the Company’s inception in 2009, Global Payout, Inc. has been a leading provider of compreh...

  • MTrac Tech Corp.

    MTrac Tech Corporation, a Nevada Corporation, is a privately held, wholly owned subsidiary of Glo...

  • Net1

    Net1 is a leading provider of transaction processing services, financial inclusion products ...

  • uBUCK Technologies SEZC

    Based in Georgetown, Cayman Islands, uBUCK Tech is a fintech enterprise that specializes in digit...

  • LiteLink Technologies Inc.

      LiteLink is a major player in developing world-class enterprise platforms that utilize ar...

  • Good Gamer Corp.

      Good Gamer Corp. is a privately-held technology company focusing on gamers and streamers....

  • BitPay

      Founded in 2011, BitPay pioneered blockchain payment processing with the mission of trans...

  • About Net1

      Net1 is a leading provider of transaction processing services, financial inclusion produc...

  • Blockchain Foundry Inc.

    Headquartered in Toronto, Canada, Blockchain Foundry (CSE:BCFN)(FWB:8BF)(OTC:BLFDF) is a global b...

  • Sixgill

    Sixgill provides a full suite of universal data automation and authenticity products and services...

Trending on TBE